Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A quadri-fluorescence SARS-CoV-2 pseudovirus system for efficient antigenic characterization of multiple circulating variants

1 Sept 2024

Abstract excerpt

The ongoing co-circulation of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains necessitates advanced methods such as high-throughput multiplex pseudovirus systems for evaluating immune responses to different variants, crucial for developing updated vaccines and neutralizing antibodies (nAbs). We have developed a quadri-fluorescence (qFluo) pseudovirus platform by four fluorescent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39243752
DOI: 10.1016/j.crmeth.2024.100856

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A quadri-fluorescence SARS-CoV-2 pseudovirus system for efficient antigenic characterization of multiple circulating variantsPMID 39243752Read ↗

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccineSemantic proximity Read ↗

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine.Semantic proximity Read ↗

A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2–Based High-Throughput Assay Useful for Vaccine Immunogenicity EvaluationSemantic proximity Read ↗

A Safe Pseudotyped Lentivirus-Based Assay to Titer SARS-CoV-2 Neutralizing AntibodiesSemantic proximity Read ↗

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1Semantic proximity Read ↗

Evaluation of Neutralizing Antibodies against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus (Vsv) Pseudovirus-Based AssaySemantic proximity Read ↗

Validation of an MLV-based SARS-CoV-2 pseudovirus neutralization assay substantiates L455S-mediated antibody escape.Semantic proximity Read ↗

Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variantsSemantic proximity Read ↗

Validation of A Triple-color Pseudovirion-based Neutralization Assay for Immunogenicity Assessment of A 14-valent Recombinant Human Papillomavirus VaccineSemantic proximity Read ↗

Evaluation of the cross reactivity of neutralising antibody response in vaccinated human and convalescent hamster sera against SARS-CoV-2 variants up to and including JN.1 using an authentic virus neutralisation assaySemantic proximity Read ↗

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2Semantic proximity Read ↗

A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern <i>in vitro</i> and <i>in vivo</i>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.